YD Bio Limited (YDES)
NASDAQ: YDES · Real-Time Price · USD
16.00
+1.75 (12.28%)
At close: Sep 26, 2025, 4:00 PM EDT
16.38
+0.38 (2.37%)
After-hours: Sep 26, 2025, 7:45 PM EDT
Company Description
YD Bio Limited a biopharmaceutical company focuses on blood-based cancer detection and develops stem cell- and exosome-based therapeutics to transform the treatment of spectrum of diseases with unmet medical needs.
The company is based in Taipei, Taiwan.
Contact Details
Address: No. 3, Xingnan St., 12F. Taipei, 115001 Taiwan | |
| Website | ydesgroup.com |
Stock Details
| Ticker Symbol | YDES |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0002011674 |
| ISIN Number | KYG983011076 |
| SIC Code | 8071 |
Key Executives
| Name | Position |
|---|---|
| J. Ramsey | Chief Executive Officer |
| J. Ramsey | Chief Financial Officer |
| Charles Ross | Chief Operating Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Sep 26, 2025 | 6-K | Report of foreign issuer |
| Sep 23, 2025 | F-1 | Registration statement for certain foreign private issuers |
| Sep 19, 2025 | 6-K | Report of foreign issuer |
| Sep 5, 2025 | 20FR12B | Filing |
| Aug 28, 2025 | CERT | Certification by an exchange approving securities for listing |
| Aug 20, 2025 | 8-A12B | Registration of securities |
| Aug 15, 2025 | 6-K | Report of foreign issuer |
| Jul 18, 2025 | EFFECT | Notice of Effectiveness |
| Jul 18, 2025 | 424B3 | Prospectus |
| Jul 16, 2025 | F-4/A | Filing |